Dr. Vjekoslav Tomaić
Ruđer Bošković Institute
Bijenička 54
HR-10000 Zagreb
Publications
Journal articles
Scientific and review papers
-
Skelin, J., Sabol, I. & Tomaić, V. (2022) Do or Die: HPV E5, E6 and E7 in Cell Death Evasion. Pathogens, 11 (9), 1027, 16 doi:10.3390/pathogens11091027.
doiwww.mdpi.comdoi.orgfulir.irb.hr -
Tomaić, V., Milutin Gašperov, N., Sabol, I. & Grce, M. (2022) HPV-associated oncogenesis in head and neck cancer. Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 144 (3-4), 106-111 doi:10.26800/lv-144-3-4-7.
doilijecnicki-vjesnik.hlz.hrfulir.irb.hr -
Milutin Gašperov, N., Sabol, I., Tomaić, V. & Grce, M. (2022) Epigenetic markers in head and neck cancer: special view on HPV-associated oropharyngeal cancer. Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 144 (3-4), 96-105 doi:10.26800/lv-144-3-4-6.
doilijecnicki-vjesnik.hlz.hrfulir.irb.hr -
Pešut, E., Đukić, A., Lulić, L., Skelin, J., Šimić, I., Gašperov, N., Tomaić, V., Sabol, I. & Grce, M. (2021) Human Papillomaviruses-Associated Cancers: An Update of Current Knowledge. Viruses-Basel, 13 (11), 2234, 32 doi:10.3390/v13112234.
doiwww.mdpi.comfulir.irb.hrdoi.org -
Lulić, L., Jakovčević, A., Manojlović, L., Dediol, E., Banks, L. & Tomaić, V. (2021) Human DLG1 and SCRIB are distinctly regulated independently of HPV-16 during the progression of oropharyngeal squamous cell carcinomas: a preliminary analysis. Cancers, 13 (17), 4461, 15 doi:10.3390/cancers13174461.
doiwww.mdpi.comfulir.irb.hr -
Kirschberg, M., Heuser, S., Marcuzzi, G., Hufbauer, M., Seeger, J., Đukić, A., Tomaić, V., Majewski, S., Wagner, S., Wittekindt, C., Würdemann, N., Klussmann, J., Quaas, A., Kashkar, H. & Akgül, B. (2020) ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers. Scientific reports, 10 (1), 17339, 12 doi:10.1038/s41598-020-74311-6.
doiwww.nature.comwww.ncbi.nlm.nih.govdoi.orgfulir.irb.hr -
Đukić, A., Lulić, L., Thomas, M., Skelin, J., Saidu, N., Grce, M., Banks, L. & Tomaić, V. (2020) HPV Oncoproteins and the Ubiquitin Proteasome System: A Signature of Malignancy?. Pathogens, 9 (2), 1-27 doi:10.3390/pathogens9020133.
doiwww.mdpi.comdoi.orgfulir.irb.hr -
Saidu, N., Filić, V., Thomas, M., Sarabia-Vega, V., Đukić, A., Miljković, F., Banks, L. & Tomaić, V. (2019) PDZ Domain-Containing Protein NHERF-2 Is a Novel Target of Human Papillomavirus 16 (HPV-16) and HPV-18. Journal of virology, 94 (1), e00663-19 doi:10.1128/JVI.00663-19.
doi -
Zine El Abidine, A., Tomaić, V., Bel Haj Rhoumaa, R., Massimi, P., Guizani, I., Boubaker, S., Ennaifera, E. & Banks, L. (2017) A naturally occurring variant of HPV-16 E7 exerts increased transforming activity through acquisition of an additional phospho-acceptor site. Virology, 500, 218-225 doi:10.1016/j.virol.2016.10.023.
doi -
Szalmás, A., Tomaić, V., Basukala, O., Massimi, P., Mittal, S., Kónya , J. & Banks, L. (2017) The PTPN14 tumour suppressor is a degradation target of Human Papillomavirus E7. Journal of virology, 91 (7), e00057-17 doi:10.1128/JVI.00057-17.
doi -
Subbaiah, V., Zhang, Z., Rajagopalan, D., Abdullah, N., Yeo-Teh, N., Tomaić, V., Banks, L., Myers, M., Chow, E. & Jha, S. (2016) E3 ligase EDD1/UBR5 is utilized by the HPV E6 oncogene to destabilize tumor suppressor TIP60. Oncogene, 35, 2062-2074 doi:10.1038/onc.2015.268.
doi -
Ganti, K., Massimi, P., Manzo-Merino, J., Tomaić, V., Pim, D., Playford, M., Marcela, L., Roberts, S., Kranjec, C., Doorbar, J. & Banks, L. (2016) Interaction of the Human Papillomavirus E6 Oncoprotein with Sorting Nexin 27 Modulates Endocytic Cargo Transport Pathways. Plos pathogens, 12, 1-22 doi:10.1371/journal.ppat.1005854.
doi -
Tomaić, V. (2016) Functional Roles of E6 and E7 Oncoproteins in HPV-Induced Malignancies at Diverse Anatomical Sites. Cancers, 8 (10), 95, 22 doi:10.3390/cancers8100095.
doifulir.irb.hrwww.mdpi.com -
Kranjec, C., Tomaić, V., Massimi, P., Nicolaides, L., Doorbar, J. & Banks, L. (2016) The high-risk HPV E6 target scribble (hScrib) is required for HPV E6 expression in cervical tumour-derived cell lines. Papillomavirus Research, 2, 70-77 doi:10.1016/j.pvr.2016.04.001.
doifulir.irb.hrwww.sciencedirect.comdoi.org -
Boon, S., Tomaić, V., Thomas, M., Roberts, S. & Banks, L. (2015) Cancer-Causing Human Papillomavirus E6 Proteins Display Major Differences in the Phospho-Regulation of Their PDZ Interactions. Journal of virology, 89 (3), 1579-1586 doi:10.1128/JVI.01961-14.
doi -
Tomaić, V. & Banks, L. (2015) Angelman syndrome-associated ubiquitin ligase UBE3A/E6AP mutants interfere with the proteolytic activity of the proteasome. Cell Death & Disease, 6, e1625-1 doi:10.1038/cddis.2014.572.
doi Ganti Ketaki, Broniarczyk Justyna, Manoubi Wiem, Massimi Paola, Mittal Suruchi, Pim David, Szalmas Anita, Thatte Jayashree, Thomas Miranda, Tomaić Vjekoslav & Banks Lawrence (2015) The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to Malignancy. Viruses-Basel, 7, 3530-3551.
-
Nagasaka, K., Pim, D., Massimi, P., Thomas, M., Tomaić, V., Subbaiah, Vanitha, Krishna, Kranjec, C., Nakagawa, S., Yano, T., Taketani, Y., Myers, M. & Banks, L. (2010) The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene, 29 (38), 5311-5321 doi:10.1038/onc.2010.265.
doi -
Tomaić, V., Pim, D. & Banks, L. (2009) The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology, 393 (1), 7-10 doi:10.1016/j.virol.2009.07.029.
doi -
Pim, D., Tomaić, V. & Banks, L. (2009) The human papillomavirus (HPV) E6* proteins from high-risk, mucosal HPVs can direct degradation of cellular proteins in the absence of full-length E6 protein.. Journal of virology, 83 (19), 9863-9874 doi:10.1128/JVI.00539-09.
doi -
Gammoh, N., Isaacson, E., Tomaić, V., Jackson, D., Doorbar, J. & Banks, L. (2009) Inhibition of HPV-16 E7 oncogenic activity by HPV- 16 E2. Oncogene, 28 (23), 2299-2304 doi:10.1038/onc.2009.78.
doi -
Tomaić, V., Gardiol, D., Massimi, P., Ozbun, M., Myers, M. & Banks, L. (2009) Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene, 28 (1), 1-8 doi:10.1038/onc.2008.365.
doi -
Thomas, M., Narayan, N., Pim, D., Tomaić, V., Massimi, P., Nagasaka, K., Kranjec, C., Gammoh, N. & Banks, L. (2008) Human papillomaviruses, cervical cancer and cell polarity. Oncogene, 27 (55), 7018-7030 doi:10.1038/onc.2008.351.
doi -
Liu, X., Disbrow, G., Yuan, H., Tomaić, V. & Schlegel, R. (2007) Myc and human papillomavirus type 16 E7 genes cooperate to immortalize human keratinocytes.. Journal of virology, 81 (22), 12689-12695 doi:10.1128/JVI.00669-07.
doi -
Liu, X., Yuan, H., Fu, B., Disbrow, G., Apolinario, T., Tomaić, V., Kelley, M., Baker, C., Huibregtse, J. & Schlegel, R. (2005) The E6AP Ubiquitin Ligase Is Required for Transactivation of the hTERT Promoter by the Human Papillomavirus E6 Oncoprotein. The Journal of biological chemistry, 280 (11), 10807-10816 doi:10.1074/jbc.M410343200.
doi